UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $3.4M invested in Proshares UltraPro NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
–
Calls
$552K
Puts
$235K
Net Calls
+$317K
Net Calls Change
+$301K
Top Buyers
1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.28M |
2 |
ACM
Avalon Capital Management
Port Of Redwood City,
California
|
+$818K |
3 |
Jane Street
New York
|
+$188K |
4 |
UBS Group
Zurich,
Switzerland
|
+$101K |
5 |
CG
Cutler Group
San Francisco,
California
|
+$9.75K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$371K |
2 |
Morgan Stanley
New York
|
-$20K |